Guideline Outlines Step-down Therapy for Asthma Guideline Outlines Step-down Therapy for Asthma

A new'yardstick'provides evidence-based guidance for stepping down therapy in patients who have achieved sustained asthma control.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Related Links:

Publication date: February 2019Source: Biomedical and Environmental Sciences, Volume 32, Issue 2Author(s): Xiao Yan GAI, Li Jiao ZHANG, Chun CHANG, Cheng Lin GUO, Mairipaiti ABULIKEMU, Wen Xiong LI, Juan WANG, Wan Zhen YAO, Xu ZHANGAbstractObjectiveTo compare the serum glycerophospholipid levels in the inflammatory subtypes of asthma by using targeted metabolomic analysis.MethodsDemographic and clinical data were collected from 51 patients with asthma between January 2015 and December 2015. Routine blood and sputum induction tests were performed. Eosinophilic asthma was defined as induced sputum containing ≥ 3% eosinoph...
Source: Biomedical and Environmental Sciences - Category: Biomedical Science Source Type: research
Yujin Zhu, Dan Mao, Wei Gao, Guojing Han, Hong Hu
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Condition:   Asthma-COPD Overlap Syndrome Interventions:   Drug: Cholecalciferol;   Other: Placebo oral capsule Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Asthma Interventions:   Drug: Fluticasone propionate pressurized metered dose inhaler;   Drug: Flovent HFA pressurized metered dose inhaler;   Drug: Placebo pressurized metered dose inhaler Sponsors:   Actavis Inc.;   Teva Pharmaceuticals USA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Asthma Chronic;   Asthma in Children Interventions:   Drug: Doxophylline;   Drug: Budesonide Sponsor:   Universidad Autonoma de Nuevo Leon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 19 March 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Bruno Sposato, Marco Scalese, Manlio Milanese, Simonetta Masieri, Carlo Cavaliere, Manuela Latorre, Nicola Scichilone, Alberto Ricci, Alberto Cresti, Pierachille Santus, Carmela Olivieri, Antonio Perrella, Paola Rogliani, Pierluigi Paggiaro, Omalizumab Study Group
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 19 March 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Sandhya Khurana, Pierluigi Paggiaro, Roland Buhl, Jonathan A. Bernstein, Jennifer Haddon, Anna Unseld, Michael Engel, Thomas B. Casale, Anne E. Dixon
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Source: Notes from Dr. RW - Category: Internal Medicine Tags: pulmonary Source Type: blogs
The rising prevalence of allergies represents an increasing socioeconomic burden. A detailed understanding of the immunological mechanisms that underlie the development of allergic disease, as well as the processes that drive immune tolerance to allergens, will be instrumental in designing therapeutic strategies to treat and prevent allergic disease. Improved characterization of individual patients through the use of specific biomarkers and improved definitions of disease endotypes are paving the way for the use of targeted therapeutic approaches for personalized treatment. Allergen-specific immunotherapy and biologic ther...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
This study provides support for creating executable software with a low investment, along with the use of a portable instrument could allow number of hospital admission due to respiratory diseases and provide support to local health managers. Furthermore, the fuzzy model is very simple and involves low computational costs, an implementation making possible.Resumo Interna ções por doenças respiratórias geram custos financeiros para o Sistema de Saúde além de custos sociais. O objetivo deste estudo foi elaborar e validar um modelo linguístico “ fuzzy ” para previs ...
Source: Ciencia e Saude Coletiva - Category: Occupational Health Source Type: research
More News: Asthma | Health